Table 1.
Reasons for delay or discontinuationin patients who received gemcitabine systemic chemotherapy
| No. of patients (%) | ||
|---|---|---|
| Non-hematological, n (%) |
Treatment delay, n = 94a |
Discontinuation of gemcitabine, n = 6 |
| Vomiting |
5 (5.3) |
0 |
| Infection |
10 (10.6) |
0 |
| Drug-induced pneumonia |
0 |
2 (33.3) |
| Diarrhea |
2 (2.1) |
0 |
| Malaise |
4 (4.3) |
1 (16.7) |
| Patient’s wish |
3 (3.2) |
0 |
| Hematological, n (%) |
|
|
| Neutrophil count decreased |
36 (38.3) |
0 |
| Anemia |
7 (7.4) |
1 (16.7) |
| Platelet count decreased |
15 (16.0) |
1 (16.7) |
| AST or ALT increased |
4 (4.3) |
0 |
| Blood bilirubin increased |
5 (5.3) |
1 (16.7) |
| Creatinine increased |
1 (1.1) |
0 |
| Hypoalbuminemia | 2 (2.1) | 0 |
Abbreviations: ALT, Alanine aminotransferase; AST, Aspartate aminotransferase.
aTotal exceeds 92 because of the duplication of patients.